
Maharishi V. Khirodhar
Examiner (ID: 10559, Phone: (571)270-7909 , Office: P/2463 )
| Most Active Art Unit | 2463 |
| Art Unit(s) | 2463, 2416 |
| Total Applications | 881 |
| Issued Applications | 739 |
| Pending Applications | 63 |
| Abandoned Applications | 97 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5182608
[patent_doc_number] => 20070053954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Macromer-melt formulations'
[patent_app_type] => utility
[patent_app_number] => 11/410269
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19377
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053954.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410269
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410269 | Macromer-melt formulations | Apr 23, 2006 | Abandoned |
Array
(
[id] => 5666643
[patent_doc_number] => 20060171993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Method of improving antioxidant status of an infant'
[patent_app_type] => utility
[patent_app_number] => 11/391798
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25805
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171993.pdf
[firstpage_image] =>[orig_patent_app_number] => 11391798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/391798 | Method of improving antioxidant status of an infant | Mar 28, 2006 | Issued |
Array
(
[id] => 8577317
[patent_doc_number] => 08343527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Photocrosslinkable oligo(poly (ethylene glycol) fumarate) hydrogels for cell and drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/909241
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 8064
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11909241
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909241 | Photocrosslinkable oligo(poly (ethylene glycol) fumarate) hydrogels for cell and drug delivery | Mar 22, 2006 | Issued |
Array
(
[id] => 5732209
[patent_doc_number] => 20060257326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods and formulations for delivery of pharmacologically active agents'
[patent_app_type] => utility
[patent_app_number] => 11/388633
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14909
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257326.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388633 | Methods and formulations for delivery of pharmacologically active agents | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5887506
[patent_doc_number] => 20060275252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Conjugates formed from polymer derivatives having particular atom arrangements'
[patent_app_type] => utility
[patent_app_number] => 11/389431
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11389431
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/389431 | Conjugates formed from polymer derivatives having particular atom arrangements | Mar 22, 2006 | Issued |
Array
(
[id] => 5595828
[patent_doc_number] => 20060159744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof'
[patent_app_type] => utility
[patent_app_number] => 11/385408
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5425
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11385408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/385408 | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof | Mar 20, 2006 | Abandoned |
Array
(
[id] => 5834268
[patent_doc_number] => 20060246098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same'
[patent_app_type] => utility
[patent_app_number] => 11/377513
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9792
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246098.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377513 | Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same | Mar 15, 2006 | Abandoned |
Array
(
[id] => 5601871
[patent_doc_number] => 20060292216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Enteric delivery of (-)-hydroxycitric acid'
[patent_app_type] => utility
[patent_app_number] => 11/371270
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8797
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292216.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371270
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371270 | Enteric delivery of (-)-hydroxycitric acid | Mar 7, 2006 | Abandoned |
Array
(
[id] => 9950590
[patent_doc_number] => 08999372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use'
[patent_app_type] => utility
[patent_app_number] => 11/371167
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12936
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11371167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371167 | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use | Mar 6, 2006 | Issued |
Array
(
[id] => 5631072
[patent_doc_number] => 20060147541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Pharmaceutical preparation for rectal administration'
[patent_app_type] => utility
[patent_app_number] => 11/362750
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7323
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11362750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/362750 | Pharmaceutical preparation for rectal administration | Feb 27, 2006 | Abandoned |
Array
(
[id] => 5630908
[patent_doc_number] => 20060147376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier'
[patent_app_type] => utility
[patent_app_number] => 11/364596
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9711
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147376.pdf
[firstpage_image] =>[orig_patent_app_number] => 11364596
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/364596 | Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5682656
[patent_doc_number] => 20060198926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'ALPHA-PYRONE COMPOSITION FOR CONTROLLING CRAVING AND AS A SUBSTITUTE FOR ALCOHOL'
[patent_app_type] => utility
[patent_app_number] => 11/307378
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2967
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198926.pdf
[firstpage_image] =>[orig_patent_app_number] => 11307378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/307378 | ALPHA-PYRONE COMPOSITION FOR CONTROLLING CRAVING AND AS A SUBSTITUTE FOR ALCOHOL | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5912414
[patent_doc_number] => 20060127476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Tranexamic acid formulations with reduced adverse effects'
[patent_app_type] => utility
[patent_app_number] => 11/346710
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14302
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346710 | Tranexamic acid formulations with reduced adverse effects | Feb 2, 2006 | Issued |
Array
(
[id] => 5912412
[patent_doc_number] => 20060127474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Pharmaceutical compositions comprising fluvastatin'
[patent_app_type] => utility
[patent_app_number] => 11/347040
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5275
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347040
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347040 | Pharmaceutical compositions comprising fluvastatin | Feb 2, 2006 | Abandoned |
Array
(
[id] => 7761250
[patent_doc_number] => 08114437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-14
[patent_title] => 'Solvent/polymer solutions as suspension vehicles'
[patent_app_type] => utility
[patent_app_number] => 11/347562
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 11248
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/114/08114437.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347562 | Solvent/polymer solutions as suspension vehicles | Feb 2, 2006 | Issued |
Array
(
[id] => 6070080
[patent_doc_number] => 20110044930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'COPOLYHYDROXYALKYLGLUTAMINES FUNCTIONALISED WITH HYDROPHOBIC GROUPS, AND USES THEREOF, ESPECIALLY IN THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 11/883223
[patent_app_country] => US
[patent_app_date] => 2006-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5802
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883223
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883223 | COPOLYHYDROXYALKYLGLUTAMINES FUNCTIONALISED WITH HYDROPHOBIC GROUPS, AND USES THEREOF, ESPECIALLY IN THERAPEUTICS | Jan 22, 2006 | Abandoned |
Array
(
[id] => 5842354
[patent_doc_number] => 20060121089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Coatings for implantable medical devices'
[patent_app_type] => utility
[patent_app_number] => 11/338058
[patent_app_country] => US
[patent_app_date] => 2006-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5780
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121089.pdf
[firstpage_image] =>[orig_patent_app_number] => 11338058
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/338058 | Coatings for implantable medical devices | Jan 22, 2006 | Issued |
Array
(
[id] => 5631041
[patent_doc_number] => 20060147510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Method for treating non-neuropathic pain'
[patent_app_type] => utility
[patent_app_number] => 11/336001
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3407
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147510.pdf
[firstpage_image] =>[orig_patent_app_number] => 11336001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/336001 | Method for treating non-neuropathic pain | Jan 19, 2006 | Abandoned |
Array
(
[id] => 5807317
[patent_doc_number] => 20060093671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Controlled release galantamine composition'
[patent_app_type] => utility
[patent_app_number] => 11/304128
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6389
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304128 | Controlled release galantamine composition | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5887505
[patent_doc_number] => 20060275251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Polymer complexes of glucuronoglucanes'
[patent_app_type] => utility
[patent_app_number] => 11/298887
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11225
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298887 | Polymer complexes of glucuronoglucanes | Dec 11, 2005 | Abandoned |